CLP
Classification
Legislation
Examples
Calculator
Contact
Sign in
Physical Hazards Health Hazards Environmental Hazards
Generic cut-off values,
M-factor
Specific and Generic concentration limits Additivity and non-additivity of hazards Labelling
Acute toxicity Skin corrosion / Irritation Serious damage to eyes / Eye irritation Respiratory / Skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity - single exposure Specific target organ toxicity - repeated exposure Aspiration Endocrine disruption for human health
Hazardous to the aquatic environment Endocrine disruption for the environment PBT and vPvB PMT and vPvM Hazardous to the ozone layer
CLP
Classification
Legislation
Examples
Calculator
Contact
Sign in
×
Classification

Health Hazards

Acute toxicity means serious adverse health effects (i.e., lethality) occurring after a single or short-term oral, dermal or inhalation exposure to a substance or mixture.

Acute oral toxicity, category 1 Acute Tox. 1: H300
Acute oral toxicity, category 2 Acute Tox. 2: H300
Acute oral toxicity, category 3 Acute Tox. 3: H301
Acute oral toxicity, category 4 Acute Tox. 4: H302
Acute dermal toxicity, category 1 Acute Tox. 1: H310
Acute dermal toxicity, category 2 Acute Tox. 2: H310
Acute dermal toxicity, category 3 Acute Tox. 3: H311
Acute dermal toxicity, category 4 Acute Tox. 4: H312
Acute inhalation toxicity, category 1 Acute Tox. 1: H330
Acute inhalation toxicity, category 2 Acute Tox. 2: H330
Acute inhalation toxicity, category 3 Acute Tox. 3: H331
Acute inhalation toxicity, category 4 Acute Tox. 4: H332

Skin corrosion means the production of irreversible damage to the skin; namely, visible necrosis through the epidermis and into the dermis occurring after exposure to a substance or mixture.
Skin irritation means the production of reversible damage to the skin occurring after exposure to a substance or mixture. (CLP, Annex I, 3.2.1).

Skin corrosion, sub-category 1A Skin Corr. 1A: H314
Skin corrosion, sub-category 1B Skin Corr. 1B: H314
Skin corrosion, sub-category 1C Skin Corr. 1C: H314
Skin corrosion, category 1 Skin Corr. 1: H314
Skin irritation, category 2 Skin Irrit. 2: H315

Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, which is not fully reversible, occurring after exposure of the eye to a substance or mixture.
Eye irritation means the production of changes in the eye, which are fully reversible, occurring after the exposure of the eye to a substance or mixture. (CLP, Annex I, 3.3.1).

Serious eye damage, category 1 Eye Dam. 1: H318
Eye irritation, category 2 Eye Irrit. 2: H319

Respiratory sensitisation means hypersensitivity of the airways occurring after inhalation of a substance or a mixture.
Skin sensitisation means an allergic response occurring after skin contact with a substance or a mixture. (CLP, Annex I, 3.4.1).

Respiratory sensitisation, category 1 Resp. Sens. 1: H334
Respiratory sensitisation, sub-category 1A Resp. Sens. 1A: H334
Respiratory sensitisation, sub-category 1B Resp. Sens. 1B: H334
Skin sensitisation, category 1 Skin Sens. 1: H317
Skin sensitisation, sub-category 1A Skin Sens. 1A: H317
Skin sensitisation, sub-category 1B Skin Sens. 1B: H317

Germ cell mutagenicity means heritable gene mutations, including heritable structural and numerical chromosome aberrations in germ cells occurring after exposure to a substance or mixture. (CLP, Annex I, 3.5.1).

Germ cell mutagenicity, category 1A Muta. 1A: H340
Germ cell mutagenicity, category 1B Muta. 1B: H340
Germ cell mutagenicity, category 2 Muta. 2: H341

Carcinogenicity means the induction of cancer or an increase in the incidence of cancer occurring after exposure to a substance or mixture. Substances and mixtures which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans. (CLP, Annex I, 3.6.1).

Carcinogenicity, category 1A Carc. 1A: H350
Carcinogenicity, category 1A Carc. 1A: H350i
Carcinogenicity, category 1B Carc. 1B: H350
Carcinogenicity, category 1B Carc. 1B: H350i
Carcinogenicity, category 2 Carc. 2: H351

Reproductive toxicity means adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring, occurring after exposure to a substance or mixture. The definitions presented below are adapted from those agreed as working definitions in IPCS/EHC Document No 225, Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. For classification purposes, the known induction of genetically based inheritable effects in the offspring is addressed in Germ Cell Mutagenicity (Section 3.5), since in the present classification system it is considered more appropriate to address such effects under the separate hazard class of germ cell mutagenicity.

In this classification system, reproductive toxicity is subdivided into two main headings:

(a) adverse effects on sexual function and fertility;
(b) adverse effects on development of the offspring.

Some reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances and mixtures with these effects shall be classified as reproductive toxicants with a general hazard statement. (CLP, Annex I, 3.7.1).

Reproductive toxicity, category 1A Repr. 1A: H360
Reproductive toxicity, category 1A Repr. 1A: H360F
Reproductive toxicity, category 1A Repr. 1A: H360Fd
Reproductive toxicity, category 1A Repr. 1A: H360FD
Reproductive toxicity, category 1A Repr. 1A: H360D
Reproductive toxicity, category 1A Repr. 1A: H360Df
Reproductive toxicity, category 1B Repr. 1B: H360
Reproductive toxicity, category 1B Repr. 1B: H360F
Reproductive toxicity, category 1B Repr. 1B: H360Fd
Reproductive toxicity, category 1B Repr. 1B: H360FD
Reproductive toxicity, category 1B Repr. 1B: H360D
Reproductive toxicity, category 1B Repr. 1B: H360Df
Reproductive toxicity, category 2 Repr. 2: H361
Reproductive toxicity, category 2 Repr. 2: H361f
Reproductive toxicity, category 2 Repr. 2: H361fd
Reproductive toxicity, category 2 Repr. 2: H361d
Category for effects on or via lactation Lact.: H362

Specific target organ toxicity – single exposure means specific, non-lethal toxic effects on target organs occurring after a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also section 3.8.1.6). (CLP, Annex I, 3.8.1).

Specific target organ toxicity - single exposure, category 1 STOT SE 1: H370
Specific target organ toxicity - single exposure, category 2 STOT SE 2: H371
Specific target organ toxicity - single exposure (respiratory tract irritation), category 3 STOT SE 3: H335
Specific target organ toxicity - single exposure (narcotic effects), category 3 STOT SE 3: H336

Specific target organ toxicity - repeated exposure means specific toxic effects on target organs occurring after repeated exposure to a substances or mixture. All significant health effects that can impair function, reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here. (CLP, Annex I, 3.9.1).

Specific target organ toxicity - repeated exposure, category 1 STOT RE 1: H372
Specific target organ toxicity - repeated exposure, category 2 STOT RE 2: H373

Aspiration hazard means severe acute effects such as chemical pneumonia, pulmonary injury or death occurring after aspiration of a substance or mixture. (CLP, Annex I, 3.10.1.3).

Aspiration hazard, category 1 Asp. Tox. 1: H304

Endocrine disruptor means a substance or a mixture that alters one or more functions of the endocrine system and consequently causes adverse effects in an intact organism, its progeny, populations or subpopulations. (CLP, Annex I, 3.11.1.1 (a)).

Endocrine disruptor for human health, category 1 ED HH 1: EUH380
Endocrine disruptor for human health, category 2 ED HH 2: EUH381